Dermapharm Holding SE (ETR:DMP)
Germany
· Delayed Price · Currency is EUR 38.40
+0.10 (0.26%)
At close: Mar 6, 2026
Dermapharm Holding SE Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 5, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 2,067 | 2,094 | 2,280 | 2,020 | 4,808 | 3,067 | Upgrade
|
| Market Cap Growth | -2.41% | -8.13% | 12.85% | -57.98% | 56.78% | 43.30% | Upgrade
|
| Enterprise Value | 2,929 | 3,007 | 3,258 | 2,493 | 5,294 | 3,584 | Upgrade
|
| Last Close Price | 38.40 | 37.89 | 40.25 | 34.88 | 79.30 | 49.94 | Upgrade
|
| PE Ratio | 17.83 | 18.41 | 36.55 | 15.05 | 22.94 | 35.73 | Upgrade
|
| Forward PE | 15.95 | 16.66 | 17.44 | 10.61 | 22.27 | 25.14 | Upgrade
|
| PS Ratio | 1.76 | 1.75 | 1.98 | 1.94 | 5.01 | 3.79 | Upgrade
|
| PB Ratio | 3.20 | 3.44 | 4.18 | 3.79 | 9.62 | 9.45 | Upgrade
|
| P/TBV Ratio | - | - | - | 41.96 | 310.95 | - | Upgrade
|
| P/FCF Ratio | 12.58 | 12.84 | 12.82 | 8.10 | 25.42 | 33.96 | Upgrade
|
| P/OCF Ratio | 10.01 | 10.40 | 10.39 | 7.00 | 19.20 | 23.39 | Upgrade
|
| EV/Sales Ratio | 2.49 | 2.52 | 2.83 | 2.40 | 5.51 | 4.43 | Upgrade
|
| EV/EBITDA Ratio | 11.08 | 11.99 | 14.79 | 8.24 | 16.95 | 23.12 | Upgrade
|
| EV/EBIT Ratio | 12.69 | 13.54 | 16.87 | 8.82 | 17.89 | 25.58 | Upgrade
|
| EV/FCF Ratio | 17.82 | 18.43 | 18.31 | 9.99 | 27.98 | 39.69 | Upgrade
|
| Debt / Equity Ratio | 1.56 | 1.63 | 2.01 | 0.97 | 1.16 | 1.87 | Upgrade
|
| Debt / EBITDA Ratio | 3.84 | 3.85 | 4.83 | 1.69 | 1.83 | 3.81 | Upgrade
|
| Debt / FCF Ratio | 6.15 | 6.07 | 6.15 | 2.07 | 3.07 | 6.72 | Upgrade
|
| Net Debt / Equity Ratio | 1.34 | 1.43 | 1.71 | 0.68 | 0.84 | 1.49 | Upgrade
|
| Net Debt / EBITDA Ratio | 3.36 | 3.46 | 4.24 | 1.20 | 1.34 | 3.12 | Upgrade
|
| Net Debt / FCF Ratio | 5.26 | 5.32 | 5.25 | 1.46 | 2.21 | 5.36 | Upgrade
|
| Asset Turnover | 0.55 | 0.56 | 0.64 | 0.74 | 0.73 | 0.71 | Upgrade
|
| Inventory Turnover | 1.22 | 1.34 | 1.55 | 1.57 | 1.56 | 1.86 | Upgrade
|
| Quick Ratio | 0.95 | 0.72 | 0.75 | 1.18 | 1.61 | 1.39 | Upgrade
|
| Current Ratio | 2.20 | 1.82 | 1.60 | 2.45 | 3.34 | 3.01 | Upgrade
|
| Return on Equity (ROE) | 18.50% | 19.38% | 11.24% | 25.69% | 50.68% | 28.21% | Upgrade
|
| Return on Assets (ROA) | 6.77% | 6.55% | 6.76% | 12.53% | 14.06% | 7.72% | Upgrade
|
| Return on Invested Capital (ROIC) | 10.31% | 9.76% | 9.29% | 19.12% | 24.46% | 12.55% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.60% | 12.70% | 10.90% | 23.70% | 23.60% | 12.80% | Upgrade
|
| Earnings Yield | 5.61% | 5.43% | 2.74% | 6.64% | 4.36% | 2.80% | Upgrade
|
| FCF Yield | 7.95% | 7.79% | 7.80% | 12.35% | 3.93% | 2.94% | Upgrade
|
| Dividend Yield | 2.34% | 2.38% | 2.19% | 3.01% | 2.74% | 1.76% | Upgrade
|
| Payout Ratio | 41.76% | 41.64% | 90.64% | 87.04% | 22.61% | 50.19% | Upgrade
|
| Buyback Yield / Dilution | 0.14% | - | - | - | - | - | Upgrade
|
| Total Shareholder Return | 2.48% | 2.38% | 2.19% | 3.01% | 2.74% | 1.76% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.